{"id":"NCT00088465","sponsor":"Eli Lilly and Company","briefTitle":"Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder","officialTitle":"An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-08","primaryCompletion":"2010-12","completion":"2010-12","firstPosted":"2004-07-27","resultsPosted":"2012-01-11","lastUpdate":"2012-01-11"},"enrollment":931,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenic Disorders","Schizoaffective Disorder"],"interventions":[{"type":"DRUG","name":"Intramuscular olanzapine depot","otherNames":["LY170053","Zyprexa Adhera"]}],"arms":[{"label":"Intramuscular Olanzapine Depot","type":"EXPERIMENTAL"}],"summary":"This is a long-term, open-label clinical study designed to enable longer-term treatment of patients completing other clinical studies with intramuscular olanzapine depot.\n\nKey objectives of the study are to:\n\n* Determine how well intramuscular (IM) olanzapine depot works during long-term treatment,\n* Evaluate the safety and tolerability of IM olanzapine depot during long-term treatment,\n* Determine the blood levels of IM olanzapine depot in patients during long-term treatment","primaryOutcome":{"measure":"Number of Participants With Adverse Events (AE)","timeFrame":"Randomization to end of study up to 76 months","effectByArm":[{"arm":"Intramuscular Olanzapine Depot","deltaMin":501,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":92,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Croatia","Czechia","France","Germany","Hungary","Israel","Italy","Mexico","Netherlands","Poland","Portugal","Puerto Rico","Romania","Russia","Slovakia","South Africa","Spain","Sweden","Taiwan"]},"refs":{"pmids":["24850228","24423017","22935168","20537130","20537128"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":170,"n":931},"commonTop":["Weight increased","Anxiety","Insomnia","Somnolence","Nasopharyngitis"]}}